Aprepitant 13668-0591
Product NDC
13668-0591- Manufacturer
- Torrent Pharmaceuticals Limited
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 21, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA211835
Need to source Aprepitant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Aprepitant | 40 mg/1 |
Drug Class
Substance P/Neurokinin-1 Receptor Antagonist [EPC]Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A4 Inducers [MoA]
Packaging Options(2)
1 BLISTER PACK in 1 CARTON (13668-591-81) / 1 CAPSULE in 1 BLISTER PACK (13668-591-80)
5 BLISTER PACK in 1 CARTON (13668-591-82) / 1 CAPSULE in 1 BLISTER PACK (13668-591-80)